OKYO Pharma(NASDAQ:OKYO) 
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-...
Website: https://www.okyopharma.com
Founded: 2007
IPO Price: $4 (May 17, 2022)
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.23
H 1.24
L 1.12
C 1.14
V 54,427
10EMA 1.14
20EMA 1.14
60EMA 1.14
120EMA 1.14
250EMA 1.14